Quantitative pharmacoproteomics investigation of anti-cancer drugs in mouse. Development and optimisation of proteomics workflows for evaluating the effect of anti-cancer drugs on mouse liver
Minimizing anti-cancer drug toxicity is a major challenge for the pharmaceutical industry. Toxicity is most frequently due to either the direct interaction of the drug on previously unidentified targets or its conversion to metabolites by drug metabolizing enzymes (e.g. CYP450 enzymes) that cause ce...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
University of Bradford
2018
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10454/15724 |